Monte Rosa Therapeutics, Inc. (GLUE)
14.22
-0.09
(-0.63%)
USD |
NASDAQ |
Sep 02, 16:00
14.23
+0.01
(+0.07%)
After-Hours: 17:53
Monte Rosa Therapeutics Net Income (TTM) : -161.12M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -161.12M |
| March 31, 2026 | -130.01M |
| December 31, 2025 | -38.63M |
| September 30, 2025 | 20.95M |
| June 30, 2025 | 24.17M |
| March 31, 2025 | 6.153M |
| December 31, 2024 | -72.70M |
| September 30, 2024 | -119.39M |
| June 30, 2024 | -130.41M |
| March 31, 2024 | -135.28M |
| December 31, 2023 | -135.35M |
| September 30, 2023 | -132.88M |
| Date | Value |
|---|---|
| June 30, 2023 | -125.32M |
| March 31, 2023 | -116.61M |
| December 31, 2022 | -108.50M |
| September 30, 2022 | -101.16M |
| June 30, 2022 | -93.68M |
| March 31, 2022 | -85.61M |
| December 31, 2021 | -73.96M |
| September 30, 2021 | -70.17M |
| June 30, 2021 | -56.90M |
| March 31, 2021 | -43.85M |
| December 31, 2020 | -35.88M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Nurix Therapeutics, Inc. | -341.35M |
| Gilead Sciences, Inc. | -3.24B |
| Ironwood Pharmaceuticals, Inc. | 129.87M |
| Capricor Therapeutics, Inc. | -129.42M |
| Cue Biopharma, Inc. | -164.11M |